Chemtech Royalty Associates, L.P. v. United States

766 F.3d 453, 2014 WL 4452768
Court of Appeals for the Fifth Circuit·Decided September 10, 2014·No. 13-30887·Published·Cited by 18 cases

Opinion

JERRY E. SMITH, Circuit Judge:

This appeal concerns the tax consequences of two transactions undertaken by Dow Chemical Company (“Dow”) and a number of foreign banks 1 from 1993 through 2006. During those years, Dow and the foreign banks purported to operate two partnerships that generated over one billion dollars in tax deductions for Dow. After a five-day trial, the district court disregarded the partnerships for tax purposes on three grounds: (1) The partnerships were shams; (2) the transactions lacked economic substance; and (3) the banks’ interests in Chemtech Royalty Associates, L.P. (“Chemtech”), were debt, not equity. The court also imposed substantial understatement and negligence penalties but refused to impose substantial-valuation or gross-valuation misstatement penalties. Because, under these specific facts, the court did not clearly err in holding that Dow lacked the intent to share the profits and losses with the foreign banks, we affirm its sham-partnership holding. In light of United States v. Woods, — U.S. —, 134 S.Ct. 557, 187 L.Ed.2d 472 (2013), however, we vacate and remand as to the penalty award.

I.

In the early 1990s, Goldman Sachs developed a financial product called Special Limited Investment Partnerships (“SLIPs”), which it promoted as a tax shelter. A series of steps typically had to be executed to create this type of product. First, the American corporation had to identify a valuable group of assets with a *456 tax basis 2 at or near zero. Second, the corporation needed to create or designate subsidiaries through which it would participate in the transaction. Those subsidiaries would then contribute the assets to the partnership. Third, the corporation had to entice foreign entities to participate in the transaction. The tax benefits generated by the partnership could be attained only if the partnership’s income could be assigned to a tax-indifferent party. Fourth, the parties would need to enter into various agreements that would govern the transaction. 3 In 1992, Dow decided to pursue this transaction, endeavoring to create an asset-backed equity financing vehicle.

Following these steps, Dow selected 73 patents to contribute to the partnership. The district court found that Dow did not select “patents that would be attractive to a third party.” Instead, it contributed those patents that (1) “had the highest value (in order to reduce the total number of patents),” (2) had a zero or near zero tax basis, and (3) were actively used by one of Dow’s businesses. For most patents, Dow “did not contribute all technology that would have been necessary for third party licensees,” requiring a potential third-party licensee to obtain licenses from both the partnership and Dow. In line with these findings, Dow selected patents valued at roughly $867 million, with 71 of the 73 patents having zero tax basis. 4

Next, Dow created two domestic subsidiaries — Diamond Technology Partnership Co. (“DTPC”) and Ifco, Inc. (“Ifco”) — and used a wholly — owned foreign subsidiary— Dow Europe, S.A. (“DESA”) — to carry out this transaction. Through these subsidiaries, Dow formed Chemtech as a Delaware limited partnership with its principal place of business in Switzerland. 5 Again through these subsidiaries, Dow contributed to Chemtech I 6 the identified 73 patents, $110 million, and all of the stock of Chemtech Portfolio, Inc. (“CPI”), a preexisting shell corporation owned by Dow.

Five foreign banks decided to participate as limited partners in Chemtech, investing a total of $200 million in the partnership. The entry of the foreign banks forced Ifco’s partnership share to be retired. By October 1993, Chemtech was owned 1% by DESA (the general partner), 81% by DTPC, and 18% by the foreign banks.

Finally, Dow and the foreign banks entered into various agreements to govern the transaction, including a patent license agreement, a partnership agreement, and various indemnity agreements. The patent license agreement allowed Dow to continue *457 to use the patents contributed to Chem-tech. Under that agreement, Dow bore responsibility for all costs related to the patents and paid a royalty to Chemtech, regardless of Dow’s use of the patents. Chemtech did not change Dow’s use of its patents. The partnership agreement, in relevant part, (1) required the maintenance of capital accounts for each partner, 7 (2) governed the allocation of profits and losses among the partners, 8 (3) limited the types of assets the partnership could hold, 9 (4) included the conditions that triggered the right to liquidate the partnership, 10 and (5) provided the manner in which assets would be allocated on liquidation. 11 Finally, because the foreign banks conditioned their willingness to participate in Chem-tech on being indemnified against any liability arising from the assets or any tax liability, Dow indemnified them against those risks.

Chemtech I operated from April 1993 through June 1998, during which time Dow’s royalty payments served as Chem-tech’s primary source of income, totaling $646 million. Because Chemtech claimed $476.1 million of book depreciation on the patents contributed to it, it reported book profits 12 of only $61.7 million, 13 out of which it paid (1) the 6.947% priority return to the foreign banks, (2) a 1% distribution to DESA, and (3) a relatively small distribution to each partner to pay its Swiss tax obligation. Chemtech then contributed the remaining cash to CPI, which loaned the bulk of the cash to Dow. Chemtech allocated the overwhelming majority of its *458 income to the foreign banks and only a fraction of its income to Dow. As the district court observed, “[w]hile Dow claimed royalty expense deductions for the money flowing to Chemtech, it did not take into account the income of the bulk of the money flowing from Chemtech.” 14

In December 1997, DESA informed the foreign banks that new tax regulations could potentially subject the banks’ priority return to a 30% withholding tax for which Dow would be responsible under the tax indemnity. In February 1998, Dow terminated Chemtech I. The foreign banks received the sum of their capital account balances, the early liquidation amounts, 1% of the increase in value of the contributed patents, and the priority return for one month. Ifco also bought out DESA’s interest as general partner.

Shortly after terminating Chemtech I, Dow began planning a similar transaction that would operate essentially the same way.

Free access — add to your briefcase to read the full text and ask questions with AI

Chemtech Royalty Associates, L.P. v. United States, 766 F.3d 453, 2014 WL 4452768 (5th Cir. 2014).

766 F.3d 453 (Chemtech Royalty Associates, L.P. v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Schorsch v. Kwarteng
Fifth Circuit, 2024
Texas Truck Parts & Tire v. United States
118 F.4th 687 (Fifth Circuit, 2024)
Randolph v. E Baton Rouge Prsh Sch Sys
19 F.4th 749 (Fifth Circuit, 2021)
Hobbs v. EVO
7 F.4th 241 (Fifth Circuit, 2021)
BCP Trading and Investments, LLC v. Cmsnr. IRS
991 F.3d 1253 (D.C. Circuit, 2021)
Estate of Frank D. Streightoff v. CIR
954 F.3d 713 (Fifth Circuit, 2020)
Ronald Becker v. Continental Motors, Inc.
709 F. App'x 263 (Fifth Circuit, 2017)
Ricky Moore v. City of Dallas, Texas
868 F.3d 398 (Fifth Circuit, 2017)
Partita Partners LLC v. United States
266 F. Supp. 3d 683 (S.D. New York, 2017)
Crummey v. Commissioner
684 F. App'x 416 (Fifth Circuit, 2017)
April Overman v. City of East Baton Rouge
656 F. App'x 664 (Fifth Circuit, 2016)
Chemtech Royalty Associates, L.P. v. United States
823 F.3d 282 (Fifth Circuit, 2016)
In re Wyly
552 B.R. 338 (N.D. Texas, 2016)
Tammie Wade v. Megan Brennan
647 F. App'x 412 (Fifth Circuit, 2016)
Brinkley v. Commissioner
808 F.3d 657 (Fifth Circuit, 2015)